Related Experiment Video
Updated: May 5, 2026

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material
Published on: August 1, 2018
Gene-expression profiles in hereditary breast cancer
I Hedenfalk1, D Duggan, Y Chen
1Cancer Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892-4470, USA.
Gene expression profiles differ between hereditary breast cancers caused by BRCA1 and BRCA2 mutations. This finding suggests that a patient's specific gene mutation influences their cancer's molecular characteristics.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Hereditary breast cancer is often linked to BRCA1 or BRCA2 gene mutations.
- Histopathological features of these cancers can correlate with the specific gene mutation.
- Distinct gene expression profiles may exist between BRCA1 and BRCA2 mutated tumors.
Purpose of the Study:
- To investigate if gene expression profiles can differentiate between BRCA1 and BRCA2 mutated breast cancers.
- To identify specific genes associated with BRCA1 and BRCA2 mutations in breast tumors.
Main Methods:
- Compared gene expression profiles from tumors of BRCA1 mutation carriers, BRCA2 mutation carriers, and sporadic breast cancer patients using microarrays.
- Analyzed 6512 complementary DNA clones representing 5361 genes.
- Employed statistical analyses to identify distinguishing gene sets between BRCA1 and BRCA2 genotypes.
Main Results:
- Gene expression profiles significantly differed among tumors with BRCA1 mutations, BRCA2 mutations, and sporadic tumors.
- Identified 176 differentially expressed genes between BRCA1 and BRCA2 mutated tumors.
- Observed functional differences between breast tumors associated with BRCA1 and BRCA2 mutations.
Conclusions:
- Breast cancers with BRCA1 and BRCA2 mutations express distinct sets of genes.
- A hereditary mutation significantly influences the gene expression profile of breast cancer.
More Related Videos
07:41Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
Published on: May 17, 2019
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020